Efficacy and Safety of Sipjeondaebo-tang on Korean Patients With Cold Hypersensitivity in the Hands and Feet (SDT)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions
Cold Hypersensitivity
Interventions
DRUG

Sipjeondaebo-tang Granule

3g, three times a day, each taken before or between meals Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

DRUG

Placebo

3g, three times a day, each taken before or between meals Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

Trial Locations (1)

Unknown

Gachon University Gil Hospital, Incheon

All Listed Sponsors
collaborator

Kyunghee University Medical Center

OTHER

collaborator

Kyung Hee University Hospital at Gangdong

OTHER

collaborator

Semyung University Affiliated Oriental Medical Hospital

OTHER

collaborator

Sangji University Oriental Medical Hospital

UNKNOWN

lead

Gachon University Gil Oriental Medical Hospital

OTHER

NCT03374345 - Efficacy and Safety of Sipjeondaebo-tang on Korean Patients With Cold Hypersensitivity in the Hands and Feet (SDT) | Biotech Hunter | Biotech Hunter